The levels of plasma DPP4 activity are elevated in diseases, including T2DM [9], obesity [9], chronic diabetic kidney disease [10], cardiovascular diseases [7] and atherosclerosis [11]. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.